AN 11 β-HYDROXYLASE INHIBITOR IN THE TREATMENT OF RESISTANT ASCITES
- 17 December 1960
- journal article
- Published by Elsevier in The Lancet
- Vol. 276 (7164), 1330-1332
- https://doi.org/10.1016/s0140-6736(60)92522-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- RESISTANT ASCITES TREATED BY COMBINED DIURETIC THERAPY: (SPIRONOLACTONE, MANNITOL, AND CHLOROTHIAZIDE)The Lancet, 1960
- CLINICAL AND METABOLIC EFFECTS OF ALDOSTERONE ANTAGONISMThe Lancet, 1959
- CLINICAL APPLICATION OF A NEW TEST OF PITUITARY RESERVE*Journal of Clinical Endocrinology & Metabolism, 1959
- Effect of Spirolactone SC 8109 on Renal Function in Normal Human Subjects.Experimental Biology and Medicine, 1959
- Regulation of Aldosterone SecretionPhysiological Reviews, 1958
- ALTERATIONS OF ADRENAL STEROID PATTERNS IN MAN RESULTING FROM TREATMENT WITH A CHEMICAL INHIBITOR OF 11 βHYDROXYLATIONJournal of Clinical Endocrinology & Metabolism, 1958
- New Amphenone analogs as adrenocortical inhibitorsCellular and Molecular Life Sciences, 1958
- Sodium Diuresis Induced by Steroidal Antagonists of AldosteroneScience, 1957
- Action of New Steroids in Blocking Effects of Aldosterone and Deoxycorticosterone on SaltScience, 1957
- AMPHENONE: TOXICITY AND EFFECTS ON ADRENAL AND THYROID FUNCTION IN MANJournal of Clinical Endocrinology & Metabolism, 1956